NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Endymed Ltd (TA: ENDY)
ENDY Technical Analysis
4
As on 4th Feb 2025 ENDY STOCK Price closed @ 320.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 331.57 & Strong Sell for SHORT-TERM with Stoploss of 372.73 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ENDYSTOCK Price
Open | 321.00 | Change | Price | % |
High | 323.00 | 1 Day | 0.00 | 0.00 |
Low | 320.00 | 1 Week | 8.10 | 2.60 |
Close | 320.00 | 1 Month | 42.50 | 15.32 |
Volume | 23880 | 1 Year | -85.00 | -20.99 |
52 Week High 405.00 | 52 Week Low 194.70 |
TA Israel Most Active Stocks
TA125 | 2008.05 | 1.06% |
BLRX | 2.10 | -4.55% |
ORL | 106.50 | 0.47% |
BEZQ | 586.30 | 0.22% |
GODM | 95.50 | -2.35% |
CANF | 1.80 | 0.00% |
DSCT | 2657.00 | 1.96% |
ELAL | 922.00 | -2.23% |
LUMI | 4563.00 | 1.40% |
POLI | 4638.00 | 1.38% |
TA Israel Top Gainers Stocks
TA Israel Top Losers Stocks
ENDY Daily Charts |
ENDY Intraday Charts |
Whats New @ Bazaartrend |
ENDY Free Analysis |
|
ENDY Important Levels Intraday
RESISTANCE | 325.78 |
RESISTANCE | 323.93 |
RESISTANCE | 322.78 |
RESISTANCE | 321.64 |
SUPPORT | 318.37 |
SUPPORT | 317.22 |
SUPPORT | 316.07 |
SUPPORT | 314.22 |
ENDY Forecast February 2025
4th UP Forecast | 483.6 |
3rd UP Forecast | 431.13 |
2nd UP Forecast | 398.7 |
1st UP Forecast | 366.27 |
1st DOWN Forecast | 273.73 |
2nd DOWN Forecast | 241.3 |
3rd DOWN Forecast | 208.87 |
4th DOWN Forecast | 156.4 |
ENDY Weekly Forecast
4th UP Forecast | 388.79 |
3rd UP Forecast | 366.73 |
2nd UP Forecast | 353.09 |
1st UP Forecast | 339.46 |
1st DOWN Forecast | 300.54 |
2nd DOWN Forecast | 286.91 |
3rd DOWN Forecast | 273.27 |
4th DOWN Forecast | 251.21 |
ENDY Forecast2025
4th UP Forecast | 724.67 |
3rd UP Forecast | 594.89 |
2nd UP Forecast | 514.67 |
1st UP Forecast | 434.45 |
1st DOWN Forecast | 205.55 |
2nd DOWN Forecast | 125.33 |
3rd DOWN Forecast | 45.11 |
4th DOWN Forecast | -84.67 |
Endymed Ltd ( TA Israel Symbol : ENDY )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ENDY Other Details
Segment | EQ | |
Market Capital | 8591992832.00 | |
Sector | Healthcare | |
Industry | Medical Devices | |
Offical website | > echo $website ; ?> |
ENDY Address
ENDY Latest News
ENDY Business Profile
Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Its products comprise EndyMed PRO, a multi-application treatment platform; PURE 2.0 that offers professional skin tightening, body contouring, and functional resurfacing; and 3DEEP radiofrequency technology, a solution for the treatment of skin tightening, wrinkle reduction, body contouring, texture enhancement, cellulite reduction, circumferential reduction, acne and acne scar reduction, stretch mark reduction, RF micro needling, and fractional resurfacing. The company was founded in 2007 and is based in Freehold, New Jersey. Address: 4400 Route 9 South, Freehold, NJ, United States, 07728
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service